VICARIOUS SURGICAL INC-A (RBOT) Fundamental Analysis & Valuation

NYSE:RBOT • US92561V2088

Current stock price

1.92 USD
-0.12 (-5.88%)
At close:
1.98 USD
+0.06 (+3.13%)
After Hours:

This RBOT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RBOT Profitability Analysis

1.1 Basic Checks

  • RBOT had negative earnings in the past year.
  • RBOT had a negative operating cash flow in the past year.
  • In the past 5 years RBOT reported 4 times negative net income.
  • RBOT had a negative operating cash flow in each of the past 5 years.
RBOT Yearly Net Income VS EBIT VS OCF VS FCFRBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • RBOT's Return On Assets of -182.62% is on the low side compared to the rest of the industry. RBOT is outperformed by 89.67% of its industry peers.
  • The Return On Equity of RBOT (-380.42%) is worse than 79.89% of its industry peers.
Industry RankSector Rank
ROA -182.62%
ROE -380.42%
ROIC N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
RBOT Yearly ROA, ROE, ROICRBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • RBOT has a Gross Margin of 5.76%. This is amonst the worse of the industry: RBOT underperforms 81.52% of its industry peers.
  • The Profit Margin and Operating Margin are not available for RBOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBOT Yearly Profit, Operating, Gross MarginsRBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. RBOT Health Analysis

2.1 Basic Checks

  • RBOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RBOT has been increased compared to 1 year ago.
  • RBOT has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RBOT Yearly Shares OutstandingRBOT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RBOT Yearly Total Debt VS Total AssetsRBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -15.74, we must say that RBOT is in the distress zone and has some risk of bankruptcy.
  • RBOT's Altman-Z score of -15.74 is on the low side compared to the rest of the industry. RBOT is outperformed by 86.96% of its industry peers.
  • RBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -15.74
ROIC/WACCN/A
WACC10.05%
RBOT Yearly LT Debt VS Equity VS FCFRBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • RBOT has a Current Ratio of 4.75. This indicates that RBOT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 4.75, RBOT is doing good in the industry, outperforming 73.37% of the companies in the same industry.
  • A Quick Ratio of 4.75 indicates that RBOT has no problem at all paying its short term obligations.
  • RBOT's Quick ratio of 4.75 is fine compared to the rest of the industry. RBOT outperforms 79.89% of its industry peers.
Industry RankSector Rank
Current Ratio 4.75
Quick Ratio 4.75
RBOT Yearly Current Assets VS Current LiabilitesRBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. RBOT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.05% over the past year.
  • Looking at the last year, RBOT shows a very strong growth in Revenue. The Revenue has grown by 160.31%.
EPS 1Y (TTM)12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.86%
Revenue 1Y (TTM)160.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, RBOT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.05% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.95%
EPS Next 2Y27.18%
EPS Next 3Y19.05%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RBOT Yearly Revenue VS EstimatesRBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 20M 40M 60M 80M 100M
RBOT Yearly EPS VS EstimatesRBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. RBOT Valuation Analysis

4.1 Price/Earnings Ratio

  • RBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year RBOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBOT Price Earnings VS Forward Price EarningsRBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBOT Per share dataRBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RBOT's earnings are expected to grow with 19.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y19.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RBOT Dividend Analysis

5.1 Amount

  • No dividends for RBOT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RBOT Fundamentals: All Metrics, Ratios and Statistics

VICARIOUS SURGICAL INC-A

NYSE:RBOT (3/2/2026, 8:04:00 PM)

After market: 1.98 +0.06 (+3.13%)

1.92

-0.12 (-5.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-16
Inst Owners33.26%
Inst Owner Change0%
Ins Owners1.9%
Ins Owner Change-0.01%
Market Cap13.67M
Revenue(TTM)21.69M
Net Income(TTM)-53.59M
Analysts43.33
Price Target5.1 (165.63%)
Short Float %1.44%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.03%
Min EPS beat(2)12.43%
Max EPS beat(2)21.62%
EPS beat(4)3
Avg EPS beat(4)11.32%
Min EPS beat(4)-2.78%
Max EPS beat(4)21.62%
EPS beat(8)5
Avg EPS beat(8)11.53%
EPS beat(12)8
Avg EPS beat(12)11.45%
EPS beat(16)9
Avg EPS beat(16)9.44%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-44.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)-9.05
EYN/A
EPS(NY)-4.15
Fwd EYN/A
FCF(TTM)-6.72
FCFYN/A
OCF(TTM)-6.68
OCFYN/A
SpS3.05
BVpS1.98
TBVpS1.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -182.62%
ROE -380.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.76%
FCFM N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.75
Quick Ratio 4.75
Altman-Z -15.74
F-Score3
WACC10.05%
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)211.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.86%
EPS Next Y23.95%
EPS Next 2Y27.18%
EPS Next 3Y19.05%
EPS Next 5YN/A
Revenue 1Y (TTM)160.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.85%
EBIT Next 3Y23.49%
EBIT Next 5YN/A
FCF growth 1Y32.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.43%
OCF growth 3YN/A
OCF growth 5YN/A

VICARIOUS SURGICAL INC-A / RBOT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of VICARIOUS SURGICAL INC-A (RBOT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to RBOT.


What is the valuation status of VICARIOUS SURGICAL INC-A (RBOT) stock?

ChartMill assigns a valuation rating of 0 / 10 to VICARIOUS SURGICAL INC-A (RBOT). This can be considered as Overvalued.


Can you provide the profitability details for VICARIOUS SURGICAL INC-A?

VICARIOUS SURGICAL INC-A (RBOT) has a profitability rating of 0 / 10.